Literature DB >> 12074360

Identification of a functional Na+/Mg2+ exchanger in human trophoblast cells.

Paul R Standley1, Cynthia A Standley.   

Abstract

BACKGROUND: Ionized magnesium levels are elevated in fetal blood compared with maternal blood, suggesting that the placenta may possess an active transport mechanism for magnesium. In the present study, we sought to determine the existence of an active transport mechanism for magnesium in the placenta using cultured trophoblast cells.
METHODS: Using choriocarcinoma cells as a model system, we attempted to demonstrate the presence of a functional Na+/Mg2+ exchanger. Human choriocarcinoma JEG-3 cells cultured on glass coverslips were loaded with MAG-Fura 2-AM (5 micromol/L x 30 min) to spectrofluorometrically assess kinetics of intracellular magnesium ([Mg2+]i). Cells were superfused with various concentrations of Na+, Mg2+, Ca2+ and imipramine, a blocker of erythrocyte Na/Mg exchange. [Mg2+]i calibration was determined via Triton X-100 and EDTA.
RESULTS: Sequential lowering of extracellular Na+ caused progressively larger, transient increases in [Mg2+]i. These transient changes in [Mg2+]i were completely dependent on [Mg]o but was independent of extracellular calcium ([Ca]o). Although acute imipramine did not alter basal [Mg2+]i, imipramine eliminated the return-to-basal phase of the [Mg2+]i transient induced by low sodium medium. Increasing extracellular magnesium ([Mg]o) caused stepwise increases in [Mg2+]i.
CONCLUSIONS: The JEG-3 cells appear to possess a functional Na/Mg exchanger that functions to maintain low [Mg2+]i in cytotrophoblast cells. In addition, [Mg2+]i is acutely regulated by [Mg]o. Because placental trophoblasts are sites of maternal-fetal ion exchange, and [Mg]o is altered in preeclampsia, derangements in or modulation of this exchanger may contribute to complications of pregnancy such as pregnancy-induced hypertension, pre-eclampsia, and preterm labor.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12074360     DOI: 10.1016/s0895-7061(02)02272-0

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  7 in total

1.  The alternative Epac/cAMP pathway and the MAPK pathway mediate hCG induction of leptin in placental cells.

Authors:  Julieta Lorena Maymó; Antonio Pérez Pérez; Bernardo Maskin; José Luis Dueñas; Juan Carlos Calvo; Víctor Sánchez Margalet; Cecilia Laura Varone
Journal:  PLoS One       Date:  2012-10-02       Impact factor: 3.240

Review 2.  Small for gestational age and magnesium in cord blood platelets: intrauterine magnesium deficiency may induce metabolic syndrome in later life.

Authors:  Junji Takaya; Kazunari Kaneko
Journal:  J Pregnancy       Date:  2010-12-28

3.  Dysregulated Erythroid Mg2+ Efflux in Type 2 Diabetes.

Authors:  Ana Ferreira; Alicia Rivera; Jay G Wohlgemuth; Jeffrey S Dlott; L Michael Snyder; Seth L Alper; Jose R Romero
Journal:  Front Cell Dev Biol       Date:  2022-04-04

4.  Leptin is an anti-apoptotic effector in placental cells involving p53 downregulation.

Authors:  Ayelén Rayen Toro; Julieta Lorena Maymó; Federico Matías Ibarbalz; Antonio Pérez-Pérez; Bernardo Maskin; Alicia Graciela Faletti; Víctor Sánchez-Margalet; Cecilia Laura Varone
Journal:  PLoS One       Date:  2014-06-12       Impact factor: 3.240

5.  Heme-mediated apoptosis and fusion damage in BeWo trophoblast cells.

Authors:  Mingli Liu; Salifu Hassana; Jonathan K Stiles
Journal:  Sci Rep       Date:  2016-10-31       Impact factor: 4.379

6.  Apelin and apelin receptor in human placenta: Expression, signalling pathway and regulation of trophoblast JEG‑3 and BeWo cells proliferation and cell cycle.

Authors:  Ewa Mlyczyńska; Patrycja Kurowska; Eliza Drwal; Małgorzata Opydo-Chanek; Wacław Tworzydło; Małgorzata Kotula-Balak; Agnieszka Rak
Journal:  Int J Mol Med       Date:  2020-01-07       Impact factor: 4.101

Review 7.  Small for Gestational Age and Magnesium: Intrauterine magnesium deficiency may induce metabolic syndrome in later life.

Authors:  Junji Takaya
Journal:  AIMS Public Health       Date:  2015-12-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.